Inovio Pharmaceuticals, Inc.
INO
$1.31
-$0.01-0.76%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 69.45% | -622.80% | 108.28% | -93.44% | -19.42% |
| Total Depreciation and Amortization | 2.74% | -1.14% | 0.59% | 1.08% | -0.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,008.10% | 94.32% | -184.01% | 1,176.92% | 159.45% |
| Change in Net Operating Assets | 88.66% | 60.24% | -421.47% | -873.73% | 101.98% |
| Cash from Operations | 16.41% | -11.46% | 10.21% | -3.66% | 22.56% |
| Capital Expenditure | -- | -- | -87.35% | -120.06% | 47.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 133.19% | 3,703.61% | -99.22% | 68.18% | 69,807.89% |
| Cash from Investing | 133.19% | 4,629.04% | -100.66% | 67.87% | 10,297.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 199.55% | -96.01% | 241.86% | -- | -100.00% |
| Repurchase of Common Stock | 56.99% | -- | 100.00% | 94.83% | 53.10% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Financing | 1,698.61% | -96.48% | 8.88% | 71,715.80% | -103.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 129.19% | -333.61% | -36.92% | 178.49% | 39.90% |